APO Research
Talk to an analyst

APO RESEARCH · REPORT

Varbenazine Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Varbenazine Capsules Market Outlook and Growth Opportunities 2026

29 December 2025193 pages

Choose your research edition.

Industry ResearchVarbenazine Capsules Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Varbenazine Capsules Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Varbenazine Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Varbenazine Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Varbenazine Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Varbenazine Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Varbenazine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Varbenazine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Varbenazine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Varbenazine Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Varbenazine Capsules market include Lupin, Neurocrine Biosciences, Zydus, Sandoz and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Varbenazine Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Varbenazine Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Varbenazine Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Varbenazine Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Varbenazine Capsules Segment by Company

Lupin

Neurocrine Biosciences

Zydus

Sandoz

Teva Pharmaceuticals

Varbenazine Capsules Segment by Type

80mg per Unit

60mg per Unit

40mg per Unit

Varbenazine Capsules Segment by Application

Hospital and Clinic

Pharmacy

Other

Varbenazine Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Varbenazine Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Varbenazine Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Varbenazine Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Varbenazine Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varbenazine Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Varbenazine Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varbenazine Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Varbenazine Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Varbenazine Capsules industry.

Chapter 3: Detailed analysis of Varbenazine Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Varbenazine Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Varbenazine Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Varbenazine Capsules Industry Trends Table 2. Varbenazine Capsules Industry Drivers Table 3. Varbenazine Capsules Industry Opportunities and Challenges Table 4. Varbenazine Capsules Industry Restraints Table 5. Global Varbenazine Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Varbenazine Capsules Revenue Share by Company (2021-2026) Table 7. Global Varbenazine Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Varbenazine Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Varbenazine Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Varbenazine Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Varbenazine Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Varbenazine Capsules Company, Product Type & Application Table 13. Global Varbenazine Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Varbenazine Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 80mg per Unit Table 18. Significant Companies of 60mg per Unit Table 19. Significant Companies of 40mg per Unit Table 20. Global Varbenazine Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Varbenazine Capsules Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Varbenazine Capsules Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Varbenazine Capsules Sales Volume Share by Type (2021-2026) Table 24. Global Varbenazine Capsules Sales Volume Share by Type (2027-2032) Table 25. Global Varbenazine Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Varbenazine Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Varbenazine Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Varbenazine Capsules Sales Value Share by Type (2021-2026) Table 29. Global Varbenazine Capsules Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital and Clinic Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Other Table 33. Global Varbenazine Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Varbenazine Capsules Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Varbenazine Capsules Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Varbenazine Capsules Sales Volume Share by Application (2021-2026) Table 37. Global Varbenazine Capsules Sales Volume Share by Application (2027-2032) Table 38. Global Varbenazine Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Varbenazine Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Varbenazine Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Varbenazine Capsules Sales Value Share by Application (2021-2026) Table 42. Global Varbenazine Capsules Sales Value Share by Application (2027-2032) Table 43. Global Varbenazine Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Varbenazine Capsules Sales by Region (2021-2026) & (K Units) Table 45. Global Varbenazine Capsules Sales Market Share by Region (2021-2026) Table 46. Global Varbenazine Capsules Sales by Region (2027-2032) & (K Units) Table 47. Global Varbenazine Capsules Sales Market Share by Region (2027-2032) Table 48. Global Varbenazine Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Varbenazine Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Varbenazine Capsules Sales Value Share by Region (2021-2026) Table 51. Global Varbenazine Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Varbenazine Capsules Sales Value Share by Region (2027-2032) Table 53. Global Varbenazine Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Varbenazine Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Varbenazine Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Varbenazine Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 58. Global Varbenazine Capsules Sales Market Share by Country (2021-2026) Table 59. Global Varbenazine Capsules Sales by Country (2027-2032) & (K Units) Table 60. Global Varbenazine Capsules Sales Market Share by Country (2027-2032) Table 61. Global Varbenazine Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Varbenazine Capsules Sales Value Market Share by Country (2021-2026) Table 63. Global Varbenazine Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Varbenazine Capsules Sales Value Market Share by Country (2027-2032) Table 65. Lupin Company Information Table 66. Lupin Business Overview Table 67. Lupin Varbenazine Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Lupin Varbenazine Capsules Product Portfolio Table 69. Lupin Recent Development Table 70. Neurocrine Biosciences Company Information Table 71. Neurocrine Biosciences Business Overview Table 72. Neurocrine Biosciences Varbenazine Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Neurocrine Biosciences Varbenazine Capsules Product Portfolio Table 74. Neurocrine Biosciences Recent Development Table 75. Zydus Company Information Table 76. Zydus Business Overview Table 77. Zydus Varbenazine Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Zydus Varbenazine Capsules Product Portfolio Table 79. Zydus Recent Development Table 80. Sandoz Company Information Table 81. Sandoz Business Overview Table 82. Sandoz Varbenazine Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sandoz Varbenazine Capsules Product Portfolio Table 84. Sandoz Recent Development Table 85. Teva Pharmaceuticals Company Information Table 86. Teva Pharmaceuticals Business Overview Table 87. Teva Pharmaceuticals Varbenazine Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Teva Pharmaceuticals Varbenazine Capsules Product Portfolio Table 89. Teva Pharmaceuticals Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Varbenazine Capsules Distributors List Table 93. Varbenazine Capsules Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Varbenazine Capsules Product Image Figure 2. Global Varbenazine Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Varbenazine Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Varbenazine Capsules Sales (2021-2032) & (K Units) Figure 5. Global Varbenazine Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Varbenazine Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 80mg per Unit Image Figure 10. 60mg per Unit Image Figure 11. 40mg per Unit Image Figure 12. Global Varbenazine Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Varbenazine Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Varbenazine Capsules Sales Volume Share by Type (2021-2032) Figure 15. Global Varbenazine Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Varbenazine Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Varbenazine Capsules Sales Value Share by Type (2021-2032) Figure 18. Hospital and Clinic Image Figure 19. Pharmacy Image Figure 20. Other Image Figure 21. Global Varbenazine Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Varbenazine Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Varbenazine Capsules Sales Volume Share by Application (2021-2032) Figure 24. Global Varbenazine Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Varbenazine Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Varbenazine Capsules Sales Value Share by Application (2021-2032) Figure 27. Global Varbenazine Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Varbenazine Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Varbenazine Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Varbenazine Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Varbenazine Capsules Sales Value (2021-2032) & (US$ Million) Figure 32. North America Varbenazine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Varbenazine Capsules Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Varbenazine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Varbenazine Capsules Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Varbenazine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Varbenazine Capsules Sales Value (2021-2032) & (US$ Million) Figure 38. South America Varbenazine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Varbenazine Capsules Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Varbenazine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Varbenazine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Varbenazine Capsules Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Varbenazine Capsules Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg per Unit
  • 60mg per Unit
  • 40mg per Unit
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Lupin
  • Neurocrine Biosciences
  • Zydus
  • Sandoz
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Varbenazine Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Varbenazine Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Varbenazine Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Varbenazine Capsules Market Dynamics
  1. 2.1 Varbenazine Capsules Industry Trends
  2. 2.2 Varbenazine Capsules Industry Drivers
  3. 2.3 Varbenazine Capsules Industry Opportunities and Challenges
  4. 2.4 Varbenazine Capsules Industry Restraints
3 Varbenazine Capsules Market by Company
  1. 3.1 Global Varbenazine Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Varbenazine Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Varbenazine Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Varbenazine Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Varbenazine Capsules Company Ranking (2024-2026)
  6. 3.6 Global Varbenazine Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Varbenazine Capsules Company Product Type and Application
  8. 3.8 Global Varbenazine Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Varbenazine Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Varbenazine Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Varbenazine Capsules Market by Type
  1. 4.1 Varbenazine Capsules Type Introduction
  2. 4.1.1 80mg per Unit
  3. 4.1.2 60mg per Unit
  4. 4.1.3 40mg per Unit
  5. 4.2 Global Varbenazine Capsules Sales Volume by Type
  6. 4.2.1 Global Varbenazine Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Varbenazine Capsules Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Varbenazine Capsules Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Varbenazine Capsules Sales Value by Type
  10. 4.3.1 Global Varbenazine Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Varbenazine Capsules Sales Value by Type (2021-2032)
  12. 4.3.3 Global Varbenazine Capsules Sales Value Share by Type (2021-2032)
5 Varbenazine Capsules Market by Application
  1. 5.1 Varbenazine Capsules Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Varbenazine Capsules Sales Volume by Application
  6. 5.2.1 Global Varbenazine Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Varbenazine Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Varbenazine Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Varbenazine Capsules Sales Value by Application
  10. 5.3.1 Global Varbenazine Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Varbenazine Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Varbenazine Capsules Sales Value Share by Application (2021-2032)
6 Varbenazine Capsules Regional Sales and Value Analysis
  1. 6.1 Global Varbenazine Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Varbenazine Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Varbenazine Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Varbenazine Capsules Sales by Region (2027-2032)
  5. 6.3 Global Varbenazine Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Varbenazine Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Varbenazine Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Varbenazine Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Varbenazine Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Varbenazine Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Varbenazine Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Varbenazine Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Varbenazine Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Varbenazine Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Varbenazine Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Varbenazine Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Varbenazine Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Varbenazine Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Varbenazine Capsules Sales Value Share by Country, 2025 VS 2032
7 Varbenazine Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Varbenazine Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Varbenazine Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Varbenazine Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Varbenazine Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Varbenazine Capsules Sales by Country (2027-2032)
  6. 7.4 Global Varbenazine Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Varbenazine Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Varbenazine Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Varbenazine Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Varbenazine Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Varbenazine Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lupin
  2. 8.1.1 Lupin Company Information
  3. 8.1.2 Lupin Business Overview
  4. 8.1.3 Lupin Varbenazine Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lupin Varbenazine Capsules Product Portfolio
  6. 8.1.5 Lupin Recent Developments
  7. 8.2 Neurocrine Biosciences
  8. 8.2.1 Neurocrine Biosciences Company Information
  9. 8.2.2 Neurocrine Biosciences Business Overview
  10. 8.2.3 Neurocrine Biosciences Varbenazine Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Neurocrine Biosciences Varbenazine Capsules Product Portfolio
  12. 8.2.5 Neurocrine Biosciences Recent Developments
  13. 8.3 Zydus
  14. 8.3.1 Zydus Company Information
  15. 8.3.2 Zydus Business Overview
  16. 8.3.3 Zydus Varbenazine Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zydus Varbenazine Capsules Product Portfolio
  18. 8.3.5 Zydus Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Varbenazine Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Varbenazine Capsules Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Teva Pharmaceuticals
  26. 8.5.1 Teva Pharmaceuticals Company Information
  27. 8.5.2 Teva Pharmaceuticals Business Overview
  28. 8.5.3 Teva Pharmaceuticals Varbenazine Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharmaceuticals Varbenazine Capsules Product Portfolio
  30. 8.5.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Varbenazine Capsules Value Chain Analysis
  2. 9.1.1 Varbenazine Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Varbenazine Capsules Sales Mode & Process
  6. 9.2 Varbenazine Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Varbenazine Capsules Distributors
  9. 9.2.3 Varbenazine Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst